| Name | Title | Contact Details |
|---|
Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel therapeutics for Alzheimer`s disease, other forms of dementia, and mechanistically related neurodegenerative disorders. Alector`s strategy is to efficiently generate and validate antibody drugs with unique functional properties that engage key disease-altering targets. This approach is enabled by a strategic alliance with Adimab, the industry leader in discovery and optimization of antibody therapeutics. Alector is currently developing leads for 4 major targets and anticipates taking 2 of these through pre-clinical development and IND enabling studies within 24 months. Alector has incorporated a highly integrated and lean biotechnology structure with extensive outsourcing that supports core scientific and management teams.
Since 1975, PSEF has provided more than $5. 3 million to plastic surgery researchers for the development of innovative procedures and treatments that benefit reconstructive and cosmetic patients today. Funding for plastic surgery research is made
Moore Norman Technology Center is a Norman, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Columbus Neighborhood Health Center is a Columbus, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
California Vein is a Stockton, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.